4 - 6 June, 2024
Excel London Platinum Suite Sebastian Hoerner, Ph.D.Senior Scientist at BiconY TherapeuticsSpeaker
Profile
Sebastian Hörner received his PhD in immunology from the University of Tübingen and worked as a postdoc at the German Cancer Research Center (DKFZ). In 2023, BiconY Therapeutics was founded as a spin-off company of the two institutions and Sebastian Hörner joined as Senior Scientist. He focuses on the discovery and characterization of novel costimulatory antibodies.
Agenda Sessions
Two Targets, Two Signals: A Combinatorial Concept for Cancer Therapy with Bispecific Antibodies Directed to CD3 and CD28
, 17:25View Session